Loxifrit 8 Tablet contains Lornoxicam 8mg, a potent non-steroidal anti-inflammatory drug (NSAID) indicated for the management of moderate to severe pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and musculoskeletal disorders. It helps in relieving joint stiffness, swelling, and functional discomfort.
Lornoxicam works by selectively inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis responsible for pain, inflammation, and fever. This mechanism ensures rapid relief and improved mobility for patients with chronic pain conditions.
For distributors and healthcare suppliers, Loxifrit 8 Tablet is a high-demand analgesic and anti-inflammatory product, widely prescribed by orthopedists, rheumatologists, and general physicians. The prevalence of arthritis, musculoskeletal pain, and post-operative inflammation drives consistent clinical demand.
Adding Loxifrit 8 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, broad therapeutic application, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.